Phase II Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Cutaneous T cell lymphoma; Peripheral T-cell lymphoma
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 22 Jul 2013 Primary endpoint 'Objective-clinical-response' has been met according to a company media release.
- 01 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History